BOSTON, Oct. 3, 2023 /PRNewswire/ -- CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, announced a milestone thirtieth patient received ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio The FDA has granted 510(k) clearance to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback